| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of Effectiveness, Safety and Optimization of Tocilizumab in a Cohort of Patients With Rheumatoid Arthritis in Clinical Practice
|
Mena-Vázquez, Natalia
|
|
2019
|
15 |
1 |
p. 21-26
|
artikel
|
| 2 |
Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus by the Mexican College of Rheumatology
|
Xibillé-Friedmann, Daniel
|
|
2019
|
15 |
1 |
p. 3-20
|
artikel
|
| 3 |
Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients
|
Restrepo-Escobar, Mauricio
|
|
2019
|
15 |
1 |
p. 27-33
|
artikel
|
| 4 |
Long-term Survival of Subcutaneous Anti-tumor Necrosis Factor Biological Drugs Administered Between 2008 and 2012 in a Cohort of Rheumatoid Arthritis Patients
|
Alvarez Rivas, Noelia
|
|
2019
|
15 |
1 |
p. 54-57
|
artikel
|
| 5 |
Nephrocalcinosis in a Patient With Rheumatoid Arthritis and Secondary Sjögren's Syndrome
|
Jiménez Liñán, Luis María
|
|
2019
|
15 |
1 |
p. 58-59
|
artikel
|
| 6 |
Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature
|
Silva-Fernández, Lucía
|
|
2019
|
15 |
1 |
p. 34-42
|
artikel
|
| 7 |
The Spanish National Commission of Specialty in the Context of Troncality
|
Izquierdo, María Galindo
|
|
2019
|
15 |
1 |
p. 1-2
|
artikel
|
| 8 |
Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies
|
Burgos-Vargas, Ruben
|
|
2019
|
15 |
1 |
p. 43-53
|
artikel
|
Tijdschrift beschrijving